Heat shock protein 90-alpha (Hsp90α)
HSP90AA1 (Heat Shock Protein 90 Alpha Family Class A Member 1) is a human gene encoding the cytosolic, stress-inducible isoform of the 90 kDa heat shock protein (HSP90α), a highly conserved ATP-dependent molecular chaperone.
HSP90AA1 (Heat Shock Protein 90 Alpha Family Class A Member 1) is a human gene encoding the cytosolic, stress-inducible isoform of the 90 kDa heat shock protein (HSP90α), a highly conserved ATP-dependent molecular chaperone. As a member of the HSP90 family, HSP90AA1 plays a central role in the folding, stabilization, maturation, and degradation of a broad repertoire of client proteins — including kinases, transcription factors, and steroid hormone receptors — thereby functioning as a master regulator of cellular proteostasis. Its expression is markedly upregulated under conditions of cellular stress, including elevated temperature, hypoxia, and oxidative stress, which has positioned it as a sentinel of the cellular stress response. HSP90AA1 is also a critical scaffold within signal transduction networks, mediating the activity of oncoproteins and pro-survival pathways such as Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB)/mTOR and signal transducer and activator of transcription 3 (STAT3)/HIF-1α, among others.
The broad involvement of HSP90AA1 in oncogenic signaling, inflammation, and metabolic disease has made it a high-priority therapeutic target across numerous disease contexts. Its overexpression in malignant tissues relative to normal counterparts enables tumor-selective targeting strategies. Beyond oncology, accumulating evidence implicates HSP90AA1 in cardiovascular diseases, neurodegeneration, fibrosis, and diabetic complications — underscoring the gene's pleiotropic biological significance and therapeutic versatility.
Where the papers sit
17 papers from the last 6 months study Heat shock protein 90-alpha (Hsp90α) directly · updated from PubMed 15 Nov 2026
Study type 0 clinical trials · 1 human data · 12 preclinical · 4 unclassified
Themes 3 themes
-
Network-Based Drug Discovery
Multi-omics, network toxicology and machine learning are being combined with molecular docking to nominate HSP90AA1-linked compounds and pathways. EGFR, beta-catenin and inflammatory signaling recur as candidate mechanisms across cancer, toxicant and autoimmune studies. FDA-approved HSP90AA1 inhibitors are being repositioned for colorectal cancer, but most evidence remains computational or exploratory. Experimental validation and clinically relevant efficacy endpoints remain open.
6 papers · 35.3%
-
Hsp90 Inhibitor Development
Small-molecule Hsp90 inhibition is being extended across AML, triple-negative breast cancer, colon cancer and SARS-CoV-2 infection. Natural-product scaffolds, evodiamine conjugates and orally active derivatives are recurring routes to improve potency and drug-like properties. Combination activity and suppression of viral protease function broaden the rationale beyond direct tumor killing. Evidence is mainly in silico or preclinical, leaving clinical selectivity, safety and efficacy unresolved.
6 papers · 35.3%
-
Oxidative Stress and Hsp90
HSP90AA1 is being linked to oxidative stress, mitochondrial dysfunction and inflammatory signaling across neurological, vascular, liver and cancer settings. Recurring mechanisms include mitophagy, reactive oxygen species, NLRP3 stability, TRPV1-eNOS signaling and HIF-1α-associated risk. The work is moving toward using HSP90AA1 as both a therapeutic target and a prognostic or mechanistic biomarker. Disease-specific validation and evidence that altering HSP90AA1 improves outcomes remain limited.
5 papers · 29.4%
Papers
The 17 papers from the last 6 months that study Heat shock protein 90-alpha (Hsp90α) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Network-Based Drug Discovery (6)
- Integrated Proteomic and Phosphoproteomic Profiling Reveals Dysregulated Inflammatory Signaling Networks in Rheumatoid Arthritis. Omics : a journal of integrative biology · 9 Oct 2026 PMID 42852684
- Integrated multi-omics, machine learning, network toxicology, and molecular docking reveal potential mechanisms underlying methyl 4-hydroxybenzoate-associated breast cancer. Molecular diversity · 28 Aug 2026 PMID 42665765
- Integrative drug repositioning identifies FDA-approved inhibitors of HSP90AA1 with therapeutic potential in colorectal cancer. Bioorganic chemistry · 21 Aug 2026 PMID 42628382
- A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer. PloS one · 1 Jul 2026 PMID 42384725
- Multi-omics investigation of per- and polyfluoroalkyl substances in lung adenocarcinoma: comprehensive network toxicology, machine learning and molecular docking experiments. Molecular diversity · 23 Jun 2026 PMID 42334505
- Studies of design, synthesis and biological properties, ADMET profiling, molecular docking, network pharmacology and molecular dynamics simulation of novel chalcone derivatives containing benzoyl-piperazin. Bioorganic chemistry · 21 May 2026 PMID 42166963
Hsp90 Inhibitor Development (6)
- Heat Shock Protein Inhibitor Tanespimycin (17AAG) Suppresses SARS-CoV-2 Main Protease Activity and Is More Potent Than Clinically Approved Antiviral Nirmatrelvir. Chembiochem : a European journal of chemical biology · 14 Aug 2026 PMID 42599674
- Discovery of a Novel HSP90-Targeting Inhibitor for AML from the Marine Aaptamine Scaffold. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593906
- Discovery of hub genes linking oxidative stress to type 2 diabetic sarcopenia using single-cell sequencing and machine learning. PloS one · 7 Jul 2026 PMID 42412755
- Exploring Bakuchiol as an HSP90-Targeting Lead Against Triple-Negative Breast Cancer: Evidence from In Silico, In Vitro, and Synergy Studies. Journal of computer-aided molecular design · 23 Jun 2026 PMID 42334659
- Integrative Database-Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma. Advanced biology · 30 May 2026 PMID 42216572
- Discovery of Novel Hsp90 Inhibitor-Evodiamine Derivative Conjugates as Potent and Orally Active Antitumor Agents for Colon Cancer Therapy. Journal of medicinal chemistry · 28 May 2026 PMID 42207984
Oxidative Stress and Hsp90 (5)
- Captopril alleviates vascular endothelial dysfunction by regulating TRPV1 and activating the eNOS pathway. European journal of pharmacology · 31 Jul 2026 PMID 42537735
- Integrated identification and validation of HSP90AA1 as a therapeutic target of Astragalus membranaceus in Alzheimer's disease. Neuroscience · 23 Jul 2026 PMID 42492887
- Development and validation of HSP90AA1 as a risk gene in a HIF-1α pathway-related prognostic signature for hepatocellular carcinoma. Biochemical and biophysical research communications · 6 Jul 2026 PMID 42407433
- Exploring Sevoflurane promotes hippocampal neuron mitophagy in elderly postoperative cognitive dysfunction by HSP90AA1 based on network pharmacology. Experimental brain research · 29 Jun 2026 PMID 42370964
- Disruption of upstream ox-LDL signaling and HSP90-mediated NLRP3 stability protects against experimental steatohepatitis. Naunyn-Schmiedeberg's archives of pharmacology · 25 May 2026 PMID 42183856
By study type
Human data, design not indexed (1)
- Discovery of hub genes linking oxidative stress to type 2 diabetic sarcopenia using single-cell sequencing and machine learning. PloS one · 7 Jul 2026 PMID 42412755
Preclinical: animal, cell and lab studies (12)
- Integrative drug repositioning identifies FDA-approved inhibitors of HSP90AA1 with therapeutic potential in colorectal cancer. Bioorganic chemistry · 21 Aug 2026 PMID 42628382
- Heat Shock Protein Inhibitor Tanespimycin (17AAG) Suppresses SARS-CoV-2 Main Protease Activity and Is More Potent Than Clinically Approved Antiviral Nirmatrelvir. Chembiochem : a European journal of chemical biology · 14 Aug 2026 PMID 42599674
- Discovery of a Novel HSP90-Targeting Inhibitor for AML from the Marine Aaptamine Scaffold. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593906
- Captopril alleviates vascular endothelial dysfunction by regulating TRPV1 and activating the eNOS pathway. European journal of pharmacology · 31 Jul 2026 PMID 42537735
- Integrated identification and validation of HSP90AA1 as a therapeutic target of Astragalus membranaceus in Alzheimer's disease. Neuroscience · 23 Jul 2026 PMID 42492887
- Development and validation of HSP90AA1 as a risk gene in a HIF-1α pathway-related prognostic signature for hepatocellular carcinoma. Biochemical and biophysical research communications · 6 Jul 2026 PMID 42407433
- A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer. PloS one · 1 Jul 2026 PMID 42384725
- Exploring Sevoflurane promotes hippocampal neuron mitophagy in elderly postoperative cognitive dysfunction by HSP90AA1 based on network pharmacology. Experimental brain research · 29 Jun 2026 PMID 42370964
- Exploring Bakuchiol as an HSP90-Targeting Lead Against Triple-Negative Breast Cancer: Evidence from In Silico, In Vitro, and Synergy Studies. Journal of computer-aided molecular design · 23 Jun 2026 PMID 42334659
- Integrative Database-Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma. Advanced biology · 30 May 2026 PMID 42216572
- Discovery of Novel Hsp90 Inhibitor-Evodiamine Derivative Conjugates as Potent and Orally Active Antitumor Agents for Colon Cancer Therapy. Journal of medicinal chemistry · 28 May 2026 PMID 42207984
- Studies of design, synthesis and biological properties, ADMET profiling, molecular docking, network pharmacology and molecular dynamics simulation of novel chalcone derivatives containing benzoyl-piperazin. Bioorganic chemistry · 21 May 2026 PMID 42166963
Unclassified: not yet indexed with MeSH (4)
- Integrated Proteomic and Phosphoproteomic Profiling Reveals Dysregulated Inflammatory Signaling Networks in Rheumatoid Arthritis. Omics : a journal of integrative biology · 9 Oct 2026 PMID 42852684
- Integrated multi-omics, machine learning, network toxicology, and molecular docking reveal potential mechanisms underlying methyl 4-hydroxybenzoate-associated breast cancer. Molecular diversity · 28 Aug 2026 PMID 42665765
- Multi-omics investigation of per- and polyfluoroalkyl substances in lung adenocarcinoma: comprehensive network toxicology, machine learning and molecular docking experiments. Molecular diversity · 23 Jun 2026 PMID 42334505
- Disruption of upstream ox-LDL signaling and HSP90-mediated NLRP3 stability protects against experimental steatohepatitis. Naunyn-Schmiedeberg's archives of pharmacology · 25 May 2026 PMID 42183856
Written from 17 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-08-30 by GPT. Drafted by language models from published abstracts; not medical advice.